Risk Factors and Molecular Mechanism of Polymyxin B Resistance in Carbapenem-Resistant Klebsiella pneumoniae Isolates from a Tertiary Hospital in Fujian, China

References

• Jin Z, Wang Z, Gong L, et al. Molecular epidemiological characteristics of carbapenem-resistant Klebsiella pneumoniae among children in China. AMB Express. 2022;12(1):89. doi:10.1186/s13568-022-01437-3
   PubMed Web of Science ®Google Scholar
• Raro OHF, Collar GS, Da Silva RMC, et al. Performance of polymyxin B agar-based tests among carbapenem-resistant Enterobacterales. Lett Appl Microbiol. 2021;72(6):767–773. doi:10.1111/lam.13467
   Web of Science ®Google Scholar
• Hu F, Guo Y, Yang Y, et al. Resistance reported from China antimicrobial surveillance network (CHINET) in 2018. Eur J Clin Microbiol Infect Dis. 2019;38(12):2275–2281. doi:10.1007/s10096-019-03673-1
   PubMed Web of Science ®Google Scholar
• Holt KE, Wertheim H, Zadoks RN, et al. Genomic analysis of diversity, population structure, virulence, and antimicrobial resistance in Klebsiella pneumoniae, an urgent threat to public health. Proc Natl Acad Sci U S A. 2015;112(27):E3574–E3581. doi:10.1073/pnas.1501049112
   PubMed Web of Science ®Google Scholar
• Zhang WX, Chen HY, Chen C, et al. Resistance phenotype and molecular epidemiology of carbapenem-resistant Klebsiella pneumoniae isolates in Shanghai. Microb Drug Resist. 2021;27(10):1312–1318. doi:10.1089/mdr.2020.0390
   PubMed Web of Science ®Google Scholar
• Zhao Y, Liao Y, Zhang N, et al. Four types of ST11 novel mutations from increasing carbapenem-resistant Klebsiella pneumoniae in Guangdong, 2016–2020. Front Microbiol. 2021;12:702941. doi:10.3389/fmicb.2021.702941
   Web of Science ®Google Scholar
• Zhang X, Li F, Cui S, et al. Prevalence and distribution characteristics of blaKPC-2 and blaNDM-1 genes in Klebsiella pneumoniae. Infect Drug Resist. 2020;13:2901–2910. doi:10.2147/IDR.S253631
   Web of Science ®Google Scholar
• Yigit H, Queenan AM, Anderson GJ, et al. Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother. 2001;45(4):1151–1161. doi:10.1128/AAC.45.4.1151-1161.2001
   PubMed Web of Science ®Google Scholar
• Liao W, Liu Y, Zhang W. Virulence evolution, molecular mechanisms of resistance and prevalence of ST11 carbapenem-resistant Klebsiella pneumoniae in China: a review over the last 10 years. J Glob Antimicrob Resist. 2020;23:174–180. doi:10.1016/j.jgar.2020.09.004
   PubMed Web of Science ®Google Scholar
• Cain AK, Boinett CJ, Barquist L, et al. Morphological, genomic and transcriptomic responses of Klebsiella pneumoniae to the last-line antibiotic colistin. Sci Rep. 2018;8(1):9868. doi:10.1038/s41598-018-28199-y
   Web of Science ®Google Scholar
• Van Duin D, Lok JJ, Earley M, et al. Colistin versus ceftazidime-avibactam in the treatment of infections due to carbapenem-resistant Enterobacteriaceae. Clin Infect Dis. 2018;66(2):163–171. doi:10.1093/cid/cix783
   PubMed Web of Science ®Google Scholar
• Perez F, El Chakhtoura NG, Yasmin M, et al. Polymyxins: to combine or not to combine? Antibiotics. 2019;8(2):38. doi:10.3390/antibiotics8020038
   Web of Science ®Google Scholar
• Poirel L, Jayol A, Nordmann P. Polymyxins: antibacterial activity, susceptibility testing, and resistance mechanisms encoded by plasmids or chromosomes. Clin Microbiol Rev. 2017;30(2):557–596. doi:10.1128/CMR.00064-16
   PubMed Web of Science ®Google Scholar
• Poirel L, Jayol A, Bontron S, et al. The mgrB gene as a key target for acquired resistance to colistin in Klebsiella pneumoniae. J Antimicrob Chemother. 2015;70(1):75–80. doi:10.1093/jac/dku323
   PubMed Web of Science ®Google Scholar
• Liu YY, Wang Y, Walsh TR, et al. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis. 2016;16(2):161–168. doi:10.1016/S1473-3099(15)00424-7
   PubMed Web of Science ®Google Scholar
• Giamarellou H. Epidemiology of infections caused by polymyxin-resistant pathogens. Int J Antimicrob Agents. 2016;48(6):614–621. doi:10.1016/j.ijantimicag.2016.09.025
   PubMed Web of Science ®Google Scholar
• Institute CaLS. Performance Standards for Antimicrobial Susceptibility Testing. In: CLSI Supplement M100. 28th ed. PA: Clinical and Laboratory Standards InstituteWayne; 2018.
   Google Scholar
• Choi Y, Chan AP. PROVEAN web server: a tool to predict the functional effect of amino acid substitutions and indels. Bioinformatics. 2015;31(16):2745–2747. doi:10.1093/bioinformatics/btv195
   PubMed Web of Science ®Google Scholar
• Haeili M, Javani A, Moradi J, et al. MgrB alterations mediate colistin resistance in Klebsiella pneumoniae isolates from Iran. Front Microbiol. 2017;8:2470. doi:10.3389/fmicb.2017.02470
   PubMed Web of Science ®Google Scholar
• Smith JL, Drum DJ, Dai Y, et al. Impact of antimicrobial usage on antimicrobial resistance in commensal Escherichia coli strains colonizing broiler chickens. Appl Environ Microbiol. 2007;73(5):1404–1414. doi:10.1128/AEM.01193-06
   PubMed Web of Science ®Google Scholar
• Nordmann P, Cuzon G, Naas T. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect Dis. 2009;9(4):228–236. doi:10.1016/S1473-3099(09)70054-4
   PubMed Web of Science ®Google Scholar
• Lan P, Jiang Y, Zhou J, et al. A global perspective on the convergence of hypervirulence and carbapenem resistance in Klebsiella pneumoniae. J Glob Antimicrob Resist. 2021;25:26–34. doi:10.1016/j.jgar.2021.02.020
   PubMed Web of Science ®Google Scholar
• Hansen GT. Continuous evolution: perspective on the epidemiology of carbapenemase resistance among enterobacterales and other gram-negative bacteria. Infect Dis Ther. 2021;10(1):75–92. doi:10.1007/s40121-020-00395-2
   PubMed Web of Science ®Google Scholar
• Yu X, Zhang W, Zhao Z, et al. Molecular characterization of carbapenem-resistant Klebsiella pneumoniae isolates with focus on antimicrobial resistance. BMC Genomics. 2019;20(1):822. doi:10.1186/s12864-019-6225-9
   PubMed Web of Science ®Google Scholar
• Rodrigues ACS, Santos ICO, Campos CC, et al. Non-clonal occurrence of pmrB mutations associated with polymyxin resistance in carbapenem-resistant Klebsiella pneumoniae in Brazil. Mem Inst Oswaldo Cruz. 2019;114:e180555. doi:10.1590/0074-02760180555
   PubMed Web of Science ®Google Scholar
• Zhang R, Liu L, Zhou H, et al. Nationwide surveillance of clinical Carbapenem-resistant Enterobacteriaceae (CRE) strains in China. EBioMedicine. 2017;19:98–106. doi:10.1016/j.ebiom.2017.04.032
   PubMed Web of Science ®Google Scholar
• Hu N, Wang D, Lin Y, et al. Molecular analysis and antimicrobial resistance pattern of tigecycline-non-susceptible K. pneumoniae isolated from a tertiary care hospital of East Asia. Infect Drug Resist. 2021;14:4147–4155. doi:10.2147/IDR.S334098
   Web of Science ®Google Scholar
• Cortazzo V, Posteraro B, Menchinelli G, et al. Susceptibility of meropenem-resistant and/or carbapenemase-producing clinical isolates of enterobacterales (Enterobacteriaceae) and pseudomonas aeruginosa to ceftazidime-avibactam and ceftolozane-tazobactam as assessed by in vitro testing methods. Antibiotics. 2022;11(8):1023. doi:10.3390/antibiotics11081023
   Web of Science ®Google Scholar
• Huang PH, Cheng YH, Chen WY, et al. Risk factors and mechanisms of in vivo emergence of colistin resistance in carbapenem-resistant Klebsiella pneumoniae. Int J Antimicrob Agents. 2021;57(6):106342. doi:10.1016/j.ijantimicag.2021.106342
   PubMed Web of Science ®Google Scholar
• zhang X, qu F, jia W, et al. Polymyxin resistance in carbapenem-resistant Enterobacteriaceae isolates from patients without polymyxin exposure: a multicentre study in China. Int J Antimicrob Agents. 2021;57(2):106262. doi:10.1016/j.ijantimicag.2020.106262
   Web of Science ®Google Scholar
• Goncalves Barbosa LC, Silva ESJA, Bordoni GP, et al. Elevated mortality risk from CRKp associated with comorbidities: systematic review and meta-analysis. Antibiotics. 2022;11(7):874. doi:10.3390/antibiotics11070874
   Web of Science ®Google Scholar
• Nang SC, Li J, Velkov T. The rise and spread of mcr plasmid-mediated polymyxin resistance. Crit Rev Microbiol. 2019;45(2):131–161. doi:10.1080/1040841X.2018.1492902
   PubMed Web of Science ®Google Scholar
• Cannatelli A, Giani T, Dapos Andrea MM, et al. MgrB inactivation is a common mechanism of colistin resistance in KPC-producing Klebsiella pneumoniae of clinical origin. Antimicrob Agents Chemother. 2014;58(10):5696–5703. doi:10.1128/AAC.03110-14
   PubMed Web of Science ®Google Scholar
• Adzitey F, Huda N, Ali GR. Molecular techniques for detecting and typing of bacteria, advantages and application to foodborne pathogens isolated from ducks. Biotech. 2013;3(2):97–107.
   Google Scholar